Study #2020-0711
Dynamics of Colonization and Infection by Multidrug-Resistant Pathogens in Immunocompromised and Critically Ill Patients (DYNAMITE)
MD Anderson Study Status
Enrolling
Treatment Agent
Description
The goal of this observational study is to investigate how bacterial populations from the intestine and mouth of patients change during the hospitalization period and evaluate if some populations of specific bacteria increase or decrease the risk of acquiring an infection or becoming colonized by pathogenic bacteria. Participants will have the following samples collected during enrollment: stool samples (maximum 2x/week), blood draws (1x/week), oral swab (1x/week).
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Antimicrobial Drug Resistance;Antibiotic Resistant Infection;Clostridium Difficile;Carbapenem-Resistant Enterobacteriaceae Infection;Extended Spectrum Beta-Lactamase Producing Bacteria Infection;Vancomycin Resistant Enterococci Infection;Carbapenem Resistant Bacterial Infection;Vancomycin-Resistant Enterococcal Infection
Study phase:
Physician name:
Samuel Shelburne
Department:
Infectious Diseases
For general questions about clinical trials:
1-855-581-8877
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.